Harmony Biosciences Holdings Capital Reinvestment Ratio
Harmony Biosciences Holdings capital reinvestment ratio. Harmony Biosciences Holdings (HRMY) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($126.15 Million) in capital expenditures ($107.00K). Check HRMY total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Harmony Biosciences Holdings (2021–2025)
Capital reinvestment ratio of Harmony Biosciences Holdings from 2021 to 2025. This chart tracks Harmony Biosciences Holdings's Capital Reinvestment Ratio across 5 annual periods. Also explore Harmony Biosciences Holdings (HRMY) equity growth momentum to track the company's year-over-year net asset growth rate.
Harmony Biosciences Holdings Capital Reinvestment Ratio by Year (2021–2025)
Harmony Biosciences Holdings capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see HRMY cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $348.20 Million | $310.00K | ▼ -83.0% |
| 2024 | 0.01x | $219.82 Million | $1.15 Million | ▲ +268.8% |
| 2023 | 0.00x | $219.39 Million | $312.00K | ▲ +19.4% |
| 2022 | 0.00x | $144.47 Million | $172.00K | ▼ -60.6% |
| 2021 | 0.00x | $98.56 Million | $298.00K | — |